2024
An Updated Simplified Severity Scale for Age-Related Macular Degeneration Incorporating Reticular Pseudodrusen Age-Related Eye Disease Study Report Number 42
Agrón E, Domalpally A, Chen Q, Lu Z, Chew E, Keenan T, Groups A. An Updated Simplified Severity Scale for Age-Related Macular Degeneration Incorporating Reticular Pseudodrusen Age-Related Eye Disease Study Report Number 42. Ophthalmology 2024, 131: 1164-1174. PMID: 38657840, PMCID: PMC11416341, DOI: 10.1016/j.ophtha.2024.04.011.Peer-Reviewed Original ResearchAge-Related Eye Disease StudyProgression to late AMDReticular pseudodrusenLate AMDFive-year ratesProgression rateAge-related macular degenerationSeverity ScaleEye Disease StudyClinical trial cohortIncrease prognostic accuracyPost hoc analysisMacular degenerationAREDS2Prognostic accuracyTrial cohortRisk featuresHoc analysisRisk categorizationPseudodrusenAge-relatedBaselineDisease StudyRiskExternal validation
2020
Predicting risk of late age-related macular degeneration using deep learning
Peng Y, Keenan T, Chen Q, Agrón E, Allot A, Wong W, Chew E, Lu Z. Predicting risk of late age-related macular degeneration using deep learning. Npj Digital Medicine 2020, 3: 111. PMID: 32904246, PMCID: PMC7453007, DOI: 10.1038/s41746-020-00317-z.Peer-Reviewed Original ResearchLate age-related macular degenerationAge-related macular degenerationHigher prognostic accuracyClinical standardsMacular degenerationPrognostic accuracyIndependent cohortLargest longitudinal clinical trialsProbability of progressionSight-threatening stagesColor fundus photographsLongitudinal clinical trialsAMD patientsRetinal specialistsClinical trialsFundus photographsSpecialty clinicHigh riskClinical actionsSurvival analysisMedical interventionsIndividual riskAREDS2AREDSExternal validation